Evidence map›Paper›PMID 23277284›Full record

ArticleMedical oncology (Northwood, London, England)2013

EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma.

Mengyan Wu, Yingxia Liu, Xiaoqing Di, Haixian Kang, Hua Zeng, Yi Zhao, Kangrong Cai, Tianyun Pang, Sen Wang, Yunhong Yao and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer.International journal of molecular sciences · 2020
    Review
  7. eIF4E Overexpression Is Associated with Poor Prognoses of Ovarian Cancer.Analytical cellular pathology (Amsterdam) · 2020
    Article
  8. Clinical Significance of Eukaryotic Initiation Factor 4E (eIF4E) Level among Cases Suffering Basal Cell Carcinoma of Skin.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Mengyan WuCancer Institute of Guangdong Medical College, No. 1 Xincheng Road, Dongguan, Guangdong Province, 523808, People's Republic of China.
Yingxia Liu
Xiaoqing Di
Haixian Kang
Hua Zeng
Yi Zhao
Kangrong Cai
Tianyun Pang
Sen Wang
Yunhong Yao
Xinrong Hu
Guangdong Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eukaryotic translation initiation factor 4E (eIF4E) is involved in integration and amplification of many carcinogenesis signals in tumors. However, it remains unclear whether eIF4E over-expresses in NPC and whether it is associated with the development of NPC. Here, we analyzed the expression state of eIF4E, c-Myc, and MMP9 in 24 nasopharyngitises and 64 nasopharyngeal carcinomas (NPC) tissues and studied the influences of eIF4E on the proliferation and cell cycle in NPC cell lines. The results indicate that eIF4E might over-express in NPC and the over-expression of eIF4E promotes NPC growth and cell cycle progression through enhancing the translational expression of c-Myc and MMP9. The finding certainly adds new knowledge in the understanding of the carcinogenesis of NPC and provides a potential molecular target for the NPC therapy and prevention.

Indexed as

Blotting, WesternCarcinomaCell CycleCell Line, TumorCell ProliferationEukaryotic Initiation Factor-4EHumansImmunohistochemistryMatrix Metalloproteinase 9Nasopharyngeal CarcinomaNasopharyngeal NeoplasmsProto-Oncogene Proteins c-mycReverse Transcriptase Polymerase Chain ReactionRNA, Small InterferingTransfectionUp-RegulationEukaryotic Initiation Factor-4EMatrix Metalloproteinase 9MYC protein, humanProto-Oncogene Proteins c-mycRNA, Small Interfering

Identifiers

PMID23277284
OpenAlexW2034851159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.